Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)

NCT01346865 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

402

Enrollment

OTHER

Sponsor class

Stopped Low Recruitment

Conditions

Coronary Artery Disease

Interventions

DRUG: Cilostazol
DRUG: Placebo

Sponsor

Seung-Jung Park

Collaborators

[object Object]